ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

Notes Payable (Details Narrative) - USD ($)	1 Months Ended			3 Months Ended
Notes Payable (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Mar. 31, 2016	Mar. 31, 2015
Debt Instrument [Line Items]
Proceeds from common stock called	$ 4,700,000	$ 9,400,000	$ 3,500,000	$ (140,086)
Unamortized discount				2,762,429
Other offering expenses				$ 166,080
Brainlab Senior Secured Note Payable [Member]
Debt Instrument [Line Items]
Stated interest rate				5.50%
Description of maturity date				Matures on December 31, 2018.
Debt face amount	4,289,444			$ 4,289,444
Description of collateral terms				The Brainlab Note is collateralized by a senior security interest in the assets of the Company.
Unamortized discount	64,835
Description of payment terms				Principal and accrued interest is payable in a single installment upon maturity.
Private Placement (Securities Purchase Agreements) [Member] \| 12% Junior Secured Notes Payable 2014 [Member] \| Warrant [Member]
Debt Instrument [Line Items]
Number of each common stock called			0.3
Number of common stock called			1,117,500
Proceeds from common stock called			$ 3,725,000
Warrant exercise price (in dollars per share)			$ 1.75
Fair value			$ 413,057
Private Placement (Securities Purchase Agreements) [Member] \| Brainlab Senior Secured Note Payable [Member]
Debt Instrument [Line Items]
Debt face amount				$ 738,000
Private Placement (Securities Purchase Agreements) [Member] \| 2014 Secured Notes [Member]
Debt Instrument [Line Items]
Debt face amount			$ 3,725,000
Maturity period			5 years
Debt frequency of periodic payment			Semi-annually
Description of collateral terms			The 2014 Secured Notes are collateralized by a security interest in the Company’s property and assets, which security interest is junior and subordinate to the security interest that collateralizes the Brainlab note.
Unamortized discount	$ 301,531		$ 413,057	280,919
Private Placement (Securities Purchase Agreements) [Member] \| 2014 Secured Notes [Member] \| Non-Employee Directors [Member]
Debt Instrument [Line Items]
Debt face amount			1,100,000
Fair value			30,210
Placement agents cash commission			$ 145,500
Number of warrants issued to placement agent			72,750
Other offering expenses			$ 76,186	$ 153,489	$ 166,080